How does genetics influence individual responses to medications and what is pharmacogenomics? Jeri explains the significance of pharmacogenomic testing in personalizing medication management, highlighting its potential to improve patient outcomes and reduce adverse effects. Through real patient stories, the discussion emphasizes the importance of genetic information in prescribing practices and the challenges faced in integrating pharmacogenomics into routine healthcare. We talk about how pharmacogenomics can help in prescribing medications for pain, depression, and acid reflux as well as other conditions. Key Takeaways: Pharmacogenomics is the study of how genetics affect medication response. Genetic testing can lead to more effective and safer medication prescriptions. Genetic information can help avoid severe side effects from medications. Pharmacogenomic testing can reduce the trial-and-error approach in medication management. Pharmacogenomics has the potential to save lives and healthcare costs. The future of pharmacogenomics looks promising but faces integration challenges. As a pharmacogenomics expert, Jeri Nichols blends over two decades of experience as a pharmacist and genetic counselor to revolutionize personalized medicine. Jeri founded GenePharmer, LLC in 2021, a consulting practice that empowers patients with safer, more effective medication regimens, and often reduces reliance on unnecessary drugs. Throughout her career, her individualized approach, rooted in listening to patients and leveraging genetic insights, has improved countless lives across private practices, medical centers, genetics labs, and community pharmacies. A passionate educator, Jeri advances PGx through lectures for students and presentations at professional healthcare meetings. Jeri invites patients and providers to explore PGx at genepharmer.com, where she is cultivating better health, one genome at a time. You can also connect with GenePharmer on LinkedIn or Facebook. genepharmer.com facebook.com/GenePharmerLLC linkedin.com/company/genepharmer-llc Please subscribe to this podcast on Apple Podcasts, Spotify, YouTube or wherever you get your podcasts to stay updated on new episodes of All Access DNA. Listen to past episodes on your favorite podcast play by searching “All Access DNA” or by streaming from our website at allaccessdna.podbean.com Here are more resources related to today’s topic: Findageneticcounselor.org to search for a genetic counselor near you CPIC guidelines Episode 16, Cancer & Chemo: Could DPYD testing save lives? Jeri’s company, GenePharmer, LLC Any inquiries on the podcast can be sent to [email protected] Note that this podcast is for entertainment and education and is not intended to be a substitute for professional medical advice. Please consult your physician with any questions you may have regarding your health. The All Access DNA team includes: host, producer and editor Kate Wilson. The logo is designed by Designs by NKJ. Our Social Media Lead is Casey Lepley.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View